Oxford Financial Group Ltd. Acquires Shares of 2,500 Horizon Therapeutics Public Limited (NASDAQ:HZNP)

Oxford Financial Group Ltd. bought a new position in Horizon Therapeutics Public Limited (NASDAQ:HZNP – Free Report) in the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor bought 2,500 shares of the biopharmaceutical company’s stock, valued at approximately $273,000. Other institutional investors and hedge […]

Related Keywords

,Horizon Therapeutics Public Limited Company ,Avoro Capital Advisors ,Horizon Therapeutics Public ,Geode Capital Management ,T Rowe Price Investment Management Inc ,Horizon Therapeutics Public Limited ,Vanguard Group Inc ,Oxford Financial Group Ltd ,Jefferies Financial Group ,Oxford Financial Group ,Free Report ,Capital Advisors ,Street Corp ,Rowe Price Investment Management ,Capital Management ,Therapeutics Public Limited ,Therapeutics Public ,Get Free Report ,Therapeutics Public Limited Company ,Visit Holdingschannel ,Horizon Therapeutics Public Daily ,Nasdaq Hznp ,Hznp ,Medical ,44047t10 ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,